❓ WA Parliamentary Question on Notice regarding referrals and treatment provided by Perth Children's Hospital Gender Diversity Service between September and December 2025, including data on biological sex, puberty blockers, cross-sex hormones, and age of patients.

For the period between 1 September 2025 and 31 December 2025:(a) how many referrals did the Perth Children’s Hospital Gender Diversity Service receive:(i) how many of these referrals were biologically male; and(ii) how many of these referrals were biologically female;(b) how many children and adolescents received treatment via the Perth Children’s Hospital Gender Diversity Service:(i) how many of these patients were biologically male; and(ii) how many of these patients were biologically female;(c) how many children and adolescents commenced stage one puberty blocker treatment:(i) how many of these patients were biologically male; and(ii) how many of these patients were biologically female;(d) how many children are currently receiving stage one puberty blocker treatment:(i) how many of these patients are biologically male; and(ii) how many of these patients are biologically female;(e) how many children commenced stage two cross-sex hormone treatment:(i) how many of these patients were biologically male; and(ii) how many of these patients were biologically female;(f) how many children and adolescents are currently receiving stage two cross-sex hormone treatment:(i) how many of these patients are biologically male; and(ii) how many of these patients are biologically female;(g) what was the age of the youngest child to receive treatment in this period; and(h) what is the age of the youngest child who has ever received treatment? For the period between 1 September 2025 and 31 December 2025: (a) how many referrals did the Perth Children’s Hospital Gender Diversity Service receive: (i) how many of these referrals were biologically male; and (ii) how many of these referrals were biologically female; (b) how many children and adolescents received treatment via the Perth Children’s Hospital Gender Diversity Service: (i) how many of these patients were biologically male; and (ii) how many of these patients were biologically female; (c) how many children and adolescents commenced stage one puberty blocker treatment: (i) how many of these patients were biologically male; and (ii) how many of these patients were biologically female; (d) how many children are currently receiving stage one puberty blocker treatment: (i) how many of these patients are biologically male; and (ii) how many of these patients are biologically female; (e) how many children commenced stage two cross-sex hormone treatment: (i) how many of these patients were biologically male; and (ii) how many of these patients were biologically female; (f) how many children and adolescents are currently receiving stage two cross-sex hormone treatment: (i) how many of these patients are biologically male; and (ii) how many of these patients are biologically female; (g) what was the age of the youngest child to receive treatment in this period; and (h) what is the age of the youngest child who has ever received treatment?

(a) (i) 27 (ii) 62 (b) (i) 86 (ii) 59 (c) (i) 6 (ii) <5 (d) (i) 48 (ii) 24 (e) (i) 5 (ii) 7 (f) (i) 43 (ii) 36 g.      11 years h.      10 years